Search research articles
Contact Us
Filters
Showing results (11-20 of 31) with videos related to
Page
of 4
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 19, 2009
Oncolytic adenoviral mutants with E1B19K gene deletions enhance gemcitabine-induced apoptosis in pancreatic carcinoma cells and anti-tumor efficacy in vivo
Stephan Leitner, Katrina Sweeney, Daniel Oberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 14, 2010
Improved potency and selectivity of an oncolytic E1ACR2 and E1B19K deleted adenoviral mutant in prostate and pancreatic cancers
Daniel Oberg, Eva Yanover, Virginie Adam, et al.
Plos One
|
October 12, 2012
Adenovirus-mediated sensitization to the cytotoxic drugs docetaxel and mitoxantrone is dependent on regulatory domains in the E1ACR1 gene-region
Enrique Miranda, Hector Maya Pineda, Daniel Öberg, et al.
Cancer Research
|
March 1, 2005
Virus-associated RNA I-deleted adenovirus, a potential oncolytic agent targeting EBV-associated tumors
Yaohe Wang, Shao-An Xue, Gunnel Hallden, et al.
Cancer Gene Therapy
|
October 23, 2004
Suicide gene therapy: conversion of ethanol to acetaldehyde mediated by human beta 2 alcohol dehydrogenase
Philip Savage, Pam Cowburn, Dahn Clemens, et al.
Journal of Virology
|
March 6, 2015
Efficiently editing the vaccinia virus genome by using the CRISPR-Cas9 system
Ming Yuan, Wensheng Zhang, Jun Wang, et al.
Cells
|
September 13, 2025
Ectopic HLA-II Expression in ESCC: Exploration of Its Relationship with Neoantigen Burden and Patient Survival
Yupei Ji, Zhizhong Wang, Zhenguo Cheng, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 30, 2003
Novel immunocompetent murine tumor models for the assessment of replication-competent oncolytic adenovirus efficacy
Gunnel Halldén, Richard Hill, Yaohe Wang, et al.
Molecular Therapy. Methods & Clinical Development
|
September 30, 2015
A marker-free system for highly efficient construction of vaccinia virus vectors using CRISPR Cas9
Ming Yuan, Xuefei Gao, Louisa S Chard, et al.
International Journal of Molecular Medicine
|
April 6, 2006
Caspase-1 as a radio- and chemo-sensitiser in vitro and in vivo
Pilar Martín-Duque, Miguel Quintanilla, Iain McNeish, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 31) with videos related to
Sort By:
Page
of 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 19, 2009
Oncolytic adenoviral mutants with E1B19K gene deletions enhance gemcitabine-induced apoptosis in pancreatic carcinoma cells and anti-tumor efficacy in vivo
Stephan Leitner, Katrina Sweeney, Daniel Oberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 14, 2010
Improved potency and selectivity of an oncolytic E1ACR2 and E1B19K deleted adenoviral mutant in prostate and pancreatic cancers
Daniel Oberg, Eva Yanover, Virginie Adam, et al.
Plos One
|
October 12, 2012
Adenovirus-mediated sensitization to the cytotoxic drugs docetaxel and mitoxantrone is dependent on regulatory domains in the E1ACR1 gene-region
Enrique Miranda, Hector Maya Pineda, Daniel Öberg, et al.
Cancer Research
|
March 1, 2005
Virus-associated RNA I-deleted adenovirus, a potential oncolytic agent targeting EBV-associated tumors
Yaohe Wang, Shao-An Xue, Gunnel Hallden, et al.
Cancer Gene Therapy
|
October 23, 2004
Suicide gene therapy: conversion of ethanol to acetaldehyde mediated by human beta 2 alcohol dehydrogenase
Philip Savage, Pam Cowburn, Dahn Clemens, et al.
Journal of Virology
|
March 6, 2015
Efficiently editing the vaccinia virus genome by using the CRISPR-Cas9 system
Ming Yuan, Wensheng Zhang, Jun Wang, et al.
Cells
|
September 13, 2025
Ectopic HLA-II Expression in ESCC: Exploration of Its Relationship with Neoantigen Burden and Patient Survival
Yupei Ji, Zhizhong Wang, Zhenguo Cheng, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 30, 2003
Novel immunocompetent murine tumor models for the assessment of replication-competent oncolytic adenovirus efficacy
Gunnel Halldén, Richard Hill, Yaohe Wang, et al.
Molecular Therapy. Methods & Clinical Development
|
September 30, 2015
A marker-free system for highly efficient construction of vaccinia virus vectors using CRISPR Cas9
Ming Yuan, Xuefei Gao, Louisa S Chard, et al.
International Journal of Molecular Medicine
|
April 6, 2006
Caspase-1 as a radio- and chemo-sensitiser in vitro and in vivo
Pilar Martín-Duque, Miguel Quintanilla, Iain McNeish, et al.
Page
of 4